Use of the urinary trypsinogen-2 dipstick test in early diagnosis of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP)

Hasan El-Garem, Enas Hamdy, Sherif Hamdy, Mohammad El-Sayed, Aisha Elsharkawy, Azmi Mohammed Saleh

Department of Clinical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt.
Department of Endemic Medicine and Hepatology, Faculty of Medicine, Cairo University, Cairo, Egypt.

DOI: 10.4236/ojgas.2013.36049                

Abstract

Background: Acute pancreatitis is one of the most serious complications of ERCP. Early diagnosis of post ERCP pancreatitis helps physicians to provide intensive care and possible medical treatment as early as possible. Trypsinogen-2 in urine is a good diagnostic and prognostic marker of acute pancreatitis. Objectives: To evaluate the diagnostic value of urinary trypsinogen-2 dipstick test for early diagnosis of post ERCP pancreatitis. Methods: A total of 37 patients with obstructive jaundice were tested with the urinary trypsinogen-2 dipstick test and serum levels of amylase and lipase before ERCP and 6 hours after ERCP. Results: Post ERCP pancreatitis was diagnosed in 6 (16%) of 37 patients. The sensitivity, specificity, positive predictive value and negative predictive value of urinary trypsinogen-2 dipstick test at 6 hours after ERCP were 100%, 97%, 86%, 100% respectively. At the cutoff level (130 U/L) for lipase, the positive predictive value and negative predictive value all were (100%), however, the positive predictive value and negative predictive value for amylase levels at cutoff (122 U/L) were 60%, 100% respectively. Serum lipase level was the best test for diagnosing post ERCP pancreatitis followed by the urinary trypsinogen-2 dipstick test. Conclusions: The urinary trypsinogen-2 dipstick test can be used as a rapid and easy test for early diagnosis of post ERCP pancreatitis with high sensitivity and specificity.

Keywords

ERCP; Pancreatitis; Urinary Trypsinogen-2 Dipstick Test

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Kobayashi, K., Sasaki, T., Serikawa, M., Inoue, M., Itsuki, H. and Chayama, K. (2011) Assessment of trypsinogen-2 levels as an early diagnostic marker for post endoscopic retrograde cholangio-pancreatography pancreatitis. Pancreas, 40, 1206-1210. http://dx.doi.org/10.1097/MPA.0b013e318223d362
[2]	Sankaralingam, S., Wesen, C., Barawi, M., Galera, R. and Lloyd, L. (2007) Use of the urinary trypsinogen-2 dip stick test in early diagnosis of pancreatitis after endoscopic retrograde cholangiopancreatography. Surgical Endoscopy, 21, 1312-1315. http://dx.doi.org/10.1007/s00464-006-9099-2
[3]	Chen, C.C., Wang, S.S., Lu, R.H., Lu, C.C., Chang, F.Y. and Lee, S.D. (2003) The early changes of serum proinflammatory and anti-inflammatory cytokines after endoscopic retrograde cholangiopancreatography. Pancreas, 26, 375-380. http://dx.doi.org/10.1097/00006676-200305000-00011
[4]	Ito, K., Fujita, N., Noda, Y., Kobayashi, G., Horaguchi, J., Takasawa, O. and Obana, T. (2007) Relationship between post-ERCP pancreatitis and the change of serum amylase level after the procedure. World Journal of Gastroenterology, 13, 3855-3860.
[5]	Chang, K., Lu, W., Zhang, K., Jia, S., Li, F., Wang, F., Deng, S. and Chen, M. (2012) Rapid urinary trypsinogen-2 test in the early diagnosis of acute pancreatitis: A meta-analysis. Clinical Biochemistry, 45, 1051-1056. http://dx.doi.org/10.1016/j.clinbiochem.2012.04.028
[6]	Kemppainen, E.A., Hedstrom, J.I., Puolakkainen, P.A., Sainio, V.S., Haapiainen, R.K., Perhoniemi, V., Osman, S., Kivilaakso, E.O. and Stenman, U.H. (1997) Rapid measurement of urinary trypsinogen-2 as a screening test for acute pancreatitis. New England Journal of Medicine, 336, 1788-1793. http://dx.doi.org/10.1056/NEJM199706193362504
[7]	Murray, B., Carter, R., Imrie, C., Evans, S. and O’Suilleabhain, C. (2003) Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology, 124, 1786-1791. http://dx.doi.org/10.1016/S0016-5085(03)00384-6
[8]	Safwat, W., Anas, A., Abdel Raouf, E., Abdel Aziz, A. and Abu EL-Ezz, M. (2011) Incidence of pancreatitis in failed versus successful ERCP and the possible benefit of pancreatic duct stenting in high risk cases. Prospective randomized study. New York Science Journal, 4, 29-32.
[9]	Sherman, S. and Lehman, G.A. (1991) ERCP-and endoscopic sphincterotomy-induced pancreatitis. Pancreas, 6, 350-367. http://dx.doi.org/10.1097/00006676-199105000-00013
[10]	Andriulli, A., Loperfido, S., Napolitano, G., Niro, G., Valvano, M.R., Spirito, F., Pilotto, A. and Forlano, R. (2007) Incidence rate of post-ERCP complications: A systematic survey of prospective studies. American Journal of Gastroenterology, 102, 1781-1788. http://dx.doi.org/10.1111/j.1572-0241.2007.01279.x
[11]	Testoni, P.A. and Bagnolo, F. (2001) Pain at 24 hours associated with amylase levels greater than 5 times the upper normal limit as the most reliable indicator of post-ERCP pancreatitis. Gastrointestinal Endoscopy, 53, 33-39. http://dx.doi.org/10.1067/mge.2001.111390
[12]	Freeman, M.L., DiSario, J.A., Nelson, D.B., Fennerty, M.B., Lee, J.G., Bjorkman, D.J., Overby, C.S., Aas, J., Ryan, M.E., Bochna, G.S., Shaw, M.J., Snady, H.W., Erickson, R.V., Moore, J.P. and Roel, J.P. (2001) Risk factors for post-ERCP pancreatitis, a prospective, multi-center study. Gastrointestinal Endoscopy, 54, 425-434. http://dx.doi.org/10.1067/mge.2001.117550
[13]	Kemppainen, E., Hedstrom, J., Puolakkainen, P., Halttunen, J., Sainio, V., Haapiainen, R. and Stenman, U.H. (1997) Urinary trypsinogen-2 test strip in detecting ERCP-induced pancreatitis. Endoscopy, 29, 247-251. http://dx.doi.org/10.1055/s-2007-1004184
[14]	Tseng, C.W., Chen, C.C., Lin, S.Z., Chang, F.Y., Lin, H.C. and Lee, S.D. (2011) Rapid urinary trypsinogen-2 test strip in the diagnosis of pancreatitis after endoscopic retrograde cholangiopancreatography. Pancreas, 40, 1211-1214. http://dx.doi.org/10.1097/MPA.0b013e31821fcdcf
[15]	Hedstrom, J., Korvuo, A., Kenkimaki, P., Tikanoja, S., Haapiainen, R., Kivilaakso, E. and Stenman, U.H. (1996) Urinary trypsinogen-2 test strip for acute pancreatitis. Lancet, 347, 729-730. http://dx.doi.org/10.1016/S0140-6736(96)90078-1
[16]	Chen, Y.K. and Pleskow, D.K. (2007) SpyGlass singleoperator peroralcholangiopancreatoscopy system for the diagnosis and therapy of bile-duct disorders: A clinical feasibility study (with video). Gastrointestinal Endoscopy, 65, 832-841. http://dx.doi.org/10.1016/j.gie.2007.01.025
[17]	Jaik, N.P., Hoey, B.A. and Stawicki, S.P. (2008) Evolving role of endoscopic retrograde cholangiopancreatography in management of extrahepatic hepatic ductal injuries due to blunt trauma: Diagnostic and treatment algorithms. HPB Surgery, 2008, Article ID: 259141.
[18]	Freeman, M.L. (2002) Adverse outcomes of ERCP. Gastrointestinal Endoscopy 56, S273-S282. http://dx.doi.org/10.1016/S0016-5107(02)70025-4